Evergreen Capital Management’s CureVac CVAC Stock Holding History

Evergreen Capital Management’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,274	Closed	-$55.5K	–	1538
2025 Q4	$55.5K	Buy	12,274 +1,592	+15%	+$8.16K	﹤0.01%	1396
2025 Q3	$57.6K	Hold	10,682	–	–	﹤0.01%	1299
2025 Q2	$58K	Sell	10,682 -4,649	-30%	-$18.4K	﹤0.01%	1117
2025 Q1	$42.5K	Buy	15,331 +1,184	+8%	+$4.12K	﹤0.01%	1083
2024 Q4	$48.2K	Buy	+14,147	New	+$40.8K	﹤0.01%	1059
2024 Q3	–	Sell	-10,491	Closed	-$35.7K	–	1015
2024 Q2	$35.7K	Sell	10,491 -935	-8%	-$3.06K	﹤0.01%	938
2024 Q1	$34.6K	Buy	+11,426	New	+$40.1K	﹤0.01%	867

Evergreen Capital Management's CVAC Position: Q1 2026 in Review

Evergreen Capital Management sold out of CureVac (CVAC) in Q1 2026, closing a stake of 12,274 shares — an estimated $55.5K sold.

Evergreen Capital Management first reported a position in CVAC in Q1 2024 and held it in 7 quarters. The position peaked at $58K in Q2 2025. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

Evergreen Capital Management reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
Evergreen Capital Management sold 12,274 CureVac shares in Q1 2026, an estimated $55.5K.
Evergreen Capital Management first reported a position in CureVac in Q1 2024 and held it in 7 quarters.
Evergreen Capital Management's CureVac position peaked at $58K in Q2 2025.
0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on Evergreen Capital Management's 13F filing for Q1 2026, filed 14 May 2026.